Eikon Therapeutics Financials - Benzinga

Eikon Therapeutics Inc

EIKNNASDAQ

Trade with Public

Trade with Public

$10.88

0.424.02%

At close: Aug 31, 5:00 PM EST

$10.88

0.424.02%

Pre-Market: 3:00 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Eikon Therapeutics Financials

Eikon Therapeutics (EIKN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Eikon Therapeutics Q2 EPS $(1.63) Misses $(1.54) Estimate

Benzinga Newsdesk

PRO
Eikon Therapeutics Q1 EPS $(2.46) Beats $(4.07) Estimate

Eikon Therapeutics (NASDAQ:EIKN) reported quarterly losses of $(2.46) per share which beat the analyst consensus estimate of $(4.07) by 39.56 percent. This is a 90.86 percent increase over losses of $(26.91) per share

Benzinga Newsdesk